Publication: EpideMiology and control measures of outBreaks due to Antibiotic-Resistant orGanisms in EurOpe (EMBARGO): a systematic review protocol.
dc.contributor.author | Babu Rajendran, Nithya | |
dc.contributor.author | Gladstone, Beryl Primrose | |
dc.contributor.author | Rodríguez-Baño, Jesús | |
dc.contributor.author | Sifakis, Frangiscos | |
dc.contributor.author | Voss, Andreas | |
dc.contributor.author | Carmeli, Yehuda | |
dc.contributor.author | Burkert, Francesco Robert | |
dc.contributor.author | Gkolia, Panagiota | |
dc.contributor.author | Tacconelli, Evelina | |
dc.contributor.authoraffiliation | [Babu Rajendran,N; Gladstone,BP; Burkert,FR; Gkolia,P; Tacconelli,A] Division of Infectious Diseases, Department of Internal Medicine 1, DZIF Partner Centre, University Hospital Tuebingen, Tuebingen, Germany. [Rodríguez-Baño,J] Department of Infectious Diseases and Clinical Microbiology, Hospital Universitario Virgen Macarena, Servicio Andaluz de Salud, Sevilla, Spain. [Sifakis,F] AstraZeneca, Gaithersburg, Maryland, USA. [Voss,A] Department of Clinical Microbiology and Infectious Diseases, Canisius-Wilhelmina Hospital. Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands. [Carmeli,Y] National Center for Antibiotic Resistance and Infection Control, Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel. | es |
dc.contributor.funder | This research project receives support from the Innovative Medicines Initiative Joint Undertaking (IMI JU) under grant agreement numbers 115737(COMBACTE-MAGNET) and 115618 (DRIVE-AB), resources of which are composed of financial contribution from the European Union Seventh Framework Programme (FP7/2007-2013) and EFPIA companies in kind contribution. In addition as a special form of the IMI JU grant, FS received a direct financial contribution from AstraZeneca. | |
dc.date.accessioned | 2017-02-21T13:00:33Z | |
dc.date.available | 2017-02-21T13:00:33Z | |
dc.date.issued | 2017-01-05 | |
dc.description | Journal Article; Erratum in: BMJ Open. 2017 Jan 27;7(1):e013634corr1 | es |
dc.description.abstract | INTRODUCTION Improving our understanding of outbreaks due to antibiotic-resistant bacteria (ARB) and their control is critical in the current public health scenario. The threat of outbreaks due to ARB requires multifaceted efforts. However, a global overview of epidemiological characteristics of outbreaks due to ARB and effective infection control measures is missing. In this paper, we describe the protocol of a systematic review aimed at mapping and characterising the epidemiological aspects of outbreaks due to ARB and infection control measures in European countries. METHODS AND ANALYSIS The databases MEDLINE, Web of Knowledge and Cochrane library will be searched using a 3-step search strategy. Selection of articles for inclusion will be performed by 2 reviewers using predefined eligibility criteria. All study designs will be included if they report an outbreak and define the microbiological methods used for microorganism identification. The target bacteria will be methicillin-resistant and vancomycin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, ceftazidime-resistant and carbapenem-resistant Acinetobacter baumannii, ceftazidime-resistant and carbapenem-resistant Pseudomonas aeruginosa, ciprofloxacin-resistant Escherichia coli, extended-spectrum β-lactamase-producing E. coli and Klebsiella pneumoniae, carbapenem-resistant and carbapenamase-producing Enterobacteriaceae. Data will be extracted using a tailored pilot tested form and the quality of reporting will be assessed using the ORION (Outbreak Reports and Intervention Studies Of Nosocomial infections) tool. Data will be synthesised and reported by the type of ARB, setting and country. Infection control measures and bundles of measures will be described. The effectiveness will be reported as defined by the authors. Regression analysis will be used to define independent factors associated with outbreaks' control. Heterogeneity between studies will be assessed by forest plots and I² statistics. ETHICS AND DISSEMINATION Ethical approval is not applicable for this study. Findings will be disseminated through journal publication and conference presentations and talks. | es |
dc.description.version | Yes | es |
dc.identifier.citation | Babu Rajendran N, Gladstone BP, Rodríguez-Baño J, Sifakis F, Voss A, Carmeli Y, et al. EpideMiology and control measures of outBreaks due to Antibiotic-Resistant orGanisms in EurOpe (EMBARGO): a systematic review protocol. BMJ Open. 2017; 7(1):e013634 | es |
dc.identifier.doi | 10.1136/bmjopen-2016-013634 | |
dc.identifier.essn | 2044-6055 | |
dc.identifier.pmc | PMC5223682 | |
dc.identifier.pmid | 28057656 | |
dc.identifier.uri | http://hdl.handle.net/10668/2586 | |
dc.journal.title | BMJ Open | |
dc.language.iso | en | |
dc.publisher | BMJ Publishing Group | es |
dc.relation.publisherversion | http://bmjopen.bmj.com/content/bmjopen/7/1/e013634.full.pdf | es |
dc.rights.accessRights | open access | |
dc.subject | Epidemiology | es |
dc.subject | Acinetobacter baumannii | es |
dc.subject | Carbapenémicos | es |
dc.subject | Ceftazidima | es |
dc.subject | Ciprofloxacino | es |
dc.subject | Infección hospitalaria | es |
dc.subject | Brotes de enfermedades | es |
dc.subject | Resistencia a la meticilina | es |
dc.subject | Staphylococcus aureus resistente a meticilina | es |
dc.subject.mesh | Medical Subject Headings::Organisms::Bacteria::Gram-Negative Bacteria::Gram-Negative Aerobic Bacteria::Gram-Negative Aerobic Rods and Cocci::Moraxellaceae::Acinetobacter::Acinetobacter baumannii | es |
dc.subject.mesh | Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Anti-Bacterial Agents | es |
dc.subject.mesh | Medical Subject Headings::Chemicals and Drugs::Organic Chemicals::Amides::Lactams::beta-Lactams::Carbapenems | es |
dc.subject.mesh | Medical Subject Headings::Chemicals and Drugs::Organic Chemicals::Amides::Lactams::beta-Lactams::Cephalosporins::Cephaloridine::Ceftazidime | es |
dc.subject.mesh | Medical Subject Headings::Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds, 2-Ring::Quinolines::Quinolones::Fluoroquinolones::Ciprofloxacin | es |
dc.subject.mesh | Medical Subject Headings::Diseases::Bacterial Infections and Mycoses::Infection::Cross Infection | es |
dc.subject.mesh | Medical Subject Headings::Health Care::Environment and Public Health::Public Health::Disease Outbreaks | es |
dc.subject.mesh | Medical Subject Headings::Organisms::Bacteria::Gram-Negative Bacteria::Gram-Negative Facultatively Anaerobic Rods::Enterobacteriaceae | es |
dc.subject.mesh | Medical Subject Headings::Organisms::Bacteria::Gram-Negative Bacteria::Gram-Negative Facultatively Anaerobic Rods::Enterobacteriaceae::Escherichia::Escherichia coli | es |
dc.subject.mesh | Medical Subject Headings::Geographicals::Geographic Locations::Europe | es |
dc.subject.mesh | Medical Subject Headings::Health Care::Environment and Public Health::Public Health::Public Health Practice::Communicable Disease Control::Infection Control | es |
dc.subject.mesh | Medical Subject Headings::Organisms::Bacteria::Gram-Negative Bacteria::Gram-Negative Facultatively Anaerobic Rods::Enterobacteriaceae::Klebsiella::Klebsiella pneumoniae | es |
dc.subject.mesh | Medical Subject Headings::Phenomena and Processes::Microbiological Phenomena::Bacterial Physiological Phenomena::Drug Resistance, Bacterial::beta-Lactam Resistance::Penicillin Resistance::Methicillin Resistance | es |
dc.subject.mesh | Medical Subject Headings::Organisms::Bacteria::Endospore-Forming Bacteria::Gram-Positive Endospore-Forming Bacteria::Gram-Positive Endospore-Forming Rods::Staphylococcaceae::Staphylococcus::Staphylococcus aureus::Methicillin-Resistant Staphylococcus aureus | es |
dc.subject.mesh | Medical Subject Headings::Organisms::Bacteria::Gram-Negative Bacteria::Gram-Negative Aerobic Bacteria::Gram-Negative Aerobic Rods and Cocci::Pseudomonadaceae::Pseudomonas::Pseudomonas aeruginosa | es |
dc.subject.mesh | Medical Subject Headings::Disciplines and Occupations::Health Occupations::Medicine::Public Health | es |
dc.subject.mesh | Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Regression Analysis | es |
dc.subject.mesh | Medical Subject Headings::Chemicals and Drugs::Carbohydrates::Glycoconjugates::Glycopeptides::Vancomycin | es |
dc.subject.mesh | Medical Subject Headings::Chemicals and Drugs::Enzymes and Coenzymes::Enzymes::Hydrolases::Amidohydrolases::beta-Lactamases | es |
dc.title | EpideMiology and control measures of outBreaks due to Antibiotic-Resistant orGanisms in EurOpe (EMBARGO): a systematic review protocol. | es |
dc.type | review article | |
dc.type.hasVersion | VoR | |
dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- BabuRajendranN_EpidemiologyControl.pdf
- Size:
- 434.85 KB
- Format:
- Adobe Portable Document Format
- Description:
- Revisión